Drontal Tasty Bone Flavoured Tablet for Dogs (single tablet)

DRONTAL® is a broad spectrum wormer that kills every type of intestinal worm commonly found in UK cats and dogs (roundworm, hookworm, whipworm and tapeworm).
Brand Drontal
Manufacturer Bayer
Species Dog
Prescription Type NFA-VPS (Animal details required)
In stock

DRONTAL®  contains febantel, pyrantel and praziquantel to effectively kill gastrointestinal roundworms and tapeworms in dogs.

Intestinal worms of dogs and cats can damage the health of your pet and can cause health issues in vulnerable people, especially children, so it is important to regularly de-worm your pet.

Adult dogs and cats should be de-wormed with DRONTAL® at least four times a year, but in some circumstances more frequent worming is necessary. For example, kittens and puppies need worming more often, as do cats that hunt and eat mice, and cats and dogs that are experiencing frequent flea problems.

The most up to date Summary of Product Characteristics for this authorised veterinary medicine can be viewed here.

The active ingredients in DRONTAL® are pyrantel embonate, which causes spastic paralysis of the parasite and allows it to be expelled by the gastrointestinal (GI) system using peristalsis; febantel, which causes structural and metabolic disturbances that exhaust the parasite's energy reserves and kill it within 2-3 days; and praziquantel, which causes severe damage to the parasite integument, resulting in contraction and paralysis.

In this fixed combination pyrantel and febantel act synergistically against roundworms (ascarides, hookworms and whipworms) in dogs. In particular, the action spectrum covers Toxocara canis, Toxascaris leonina, Uncinaria stenocephala, Ancylostoma caninum, and Trichuris vulpis.

The spectrum of activity of praziquantel covers tapeworm species in dogs. In particular, it includes all Taenia species, as well as Multiceps multiceps, Dipylidium caninum, Echinococcus granulosus and Echinococcus multilocularis. Praziquantel acts against all intestinal stage of these parasites.

As a precautionary measure to prevent the establishment of Echinococcus multilocularis in the UK and Ireland, it is recommended that all dogs and cats entering the country be treated with praziquantel.

One tablet in a foil blister.

Active substance :

150 mg febantel
50 mg pyrantel equivalent to 144 mg pyrantel embonate
50 mg praziquantel

Excipients :

Maize starch
Lactose monohydrate
Microcrystalline cellulose
Povidone K25
Magnesium stearate
Sodium laurilsulfate
Colloidal anhydrous silica
Croscarmellose sodium
Meat flavour

For treatment of dogs, 1 tablet per 10 kg body weight (15 mg febantel, 14.4 mg pyrantel embonate and 5 mg praziquantel/kg body weight).

Body weight (kg)  Tablet quantity
2-5  ½
>5-10  1
>10-15 1 ½
>15-20 2

For each additional 5 kg bodyweight, administer an additional half tablet. Any part-used tablets should be discarded.

Administration and Duration of Treatment:

Single oral administration. 

The tablets are flavoured and studies have shown that they are palatable and are taken voluntarily by the majority (88%) of dogs tested.
The tablets can be administered with or without food. Access to normal diet does not need to be limited before or after treatment.

Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc is undertaken.

The advice of a veterinarian should be sought regarding the need for and frequency of repeat treatment.

Since it contains praziquantel, the product is effective against Echinococcus spp. which do not occur in all EU member states but are becoming more common in some.  Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the World Organisation for Animal Health (OIE), specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.

Special precautions for use in animals

  • Not for use in dogs weighing less than 2 kg.
  • Do not use at the same time as using piperazine-containing products.
  • Do not use in case of hypersensitivity to the active substances or to any of the excipients.
  • Do not use during the 1st and 2nd third of pregnancy. A single treatment during the last third of pregnancy or during lactation has been demonstrated safe.
  • Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.
  • To minimise the risk of reinfestation and new infestation, dog droppings should be collected and properly disposed of for 24 hours following treatment.

Special precautions to be taken by the person administering the medicinal product to animals

  • In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
  • In the interests of good hygiene, persons administering the product directly to a dog or by adding it to the dog’s food should wash their hands afterwards.

Adverse reactions

In very rare cases mild and transient digestive tract disorders (e.g. vomiting) may occur. If you see any adverse signs please notify your veterinary surgeon.

For more information on Drontal® and Advantage®, and answers to FAQ, see www.drontal.com.

Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account